![]() |
市场调查报告书
商品编码
1746933
日本辅助生殖技术市场报告(按产品、类型(体外受精、人工授精)、最终用途和地区)2025-2033Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2025-2033 |
2024年,日本辅助生殖技术市场规模达35.247亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到63.29亿美元,2025-2033年期间的复合年增长率(CAGR)为6.7%。日本不孕症盛行率的上升、政府推出的支持措施、辅助生殖技术(ART)的近期技术进步,以及社会对不孕症治疗的认知度和接受度的提高,是推动市场发展的一些关键因素。
辅助生殖技术 (ART) 是指主要用于治疗不孕症的医疗程序。它涵盖多种方法,例如体外受精 (IVF)、卵胞浆内单一精子注射 (ICSI)、配子或胚胎冷冻保存以及生育药物治疗。 ART 具有许多优势,例如能够绕过受精过程中的生理障碍、提高配子品质或维持生育能力。它融合了医学专业知识、先进的实验室、法律框架和伦理管理。 ART 被不孕夫妇、单身人士以及渴望成为父母的男女同性恋群体广泛使用。此外,它还可用于预防遗传性疾病、平衡家庭关係、促进代孕以及癌症患者的生育能力保存。 ART 可以提高受孕几率、控制受孕时机、筛检遗传疾病,并增进人们对自身生育能力的了解。除此之外,它还提供了许多优势,例如多次怀孕的选择以及允许同性伴侣或单亲父母怀孕。
由于生活方式的改变和老龄人口的增加,日本不孕症的盛行率不断上升,这是推动市场成长的关键因素之一。此外,政府推出的支持措施,例如补贴辅助生殖技术(ART)以鼓励夫妻寻求治疗,也正在推动市场成长。此外,辅助生殖技术(ART)的最新技术进步提高了成功率,从而促进了其应用,也催化了市场成长。此外,社会对不孕症治疗的认识和接受度不断提高,也促进了市场成长。此外,监管框架的持续改进为潜在患者提供了安全保障,也推动了市场成长。此外,日本可支配收入的增加,使更多人能够负担得起通常昂贵的辅助生殖技术(ART)等治疗,这也促进了市场成长。此外,主要参与者不断增加对研发和创新的投资,以开发有效的不孕症治疗方案,也对市场成长产生了正面影响。此外,日本和国际生育诊所之间日益增多的合作,旨在扩大最佳实践和先进治疗手段的可及性,也支持了市场成长。同时,日本文化中日益增长的社会压力和家庭创造慾望正在推动市场成长。此外,生育旅游的兴起,使人们能够前往日本享受高品质的辅助生殖技术 (ART) 服务,也刺激了市场成长。此外,辅助生殖技术服务扩展到更广泛的人群,包括老年女性和单身人士,开闢了新的细分市场,也加速了市场的成长。此外,基因筛检技术的最新进展使辅助生殖技术更加安全可靠,这也正在加强全国市场的成长。
市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
Japan assisted reproductive technology market size reached USD 3,524.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,329.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.
Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.
The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.